BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Richard Brudnick to join InflaRx Board of Directors

  InflaRx N.V. announced that Mr. Richard Brudnick has been appointed, as interim Non-Executive Director to the Board of Directors of InflaRx N.V.

  February 14, 2019

   · 

  4 min read
• 

  Drug Development

  Ultragenyx and Kyowa Kirin Announce Positive 64-Week Results for Crysvita® (burosumab) from Phase 3 Study in Children with X-linked Hypophosphatemia (XLH)

  Results Confirm and Extend 40-Week Findings that Treatment with Crysvita is Superior to Conventional Therapy

  February 14, 2019

   · 

  13 min read
• 

  Biotech Beach

  Retrophin to Present at the 8th Annual SVB Leerink Global Healthcare Conference

  Retrophin, Inc. announced that Eric Dube, Ph.D., chief executive officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York Cityon Thursday, February 28, 2019 at 3:30 p.m. ET.

  February 14, 2019

   · 

  1 min read
• Business

  Clearside Biomedical’s Suprachoroidal Injection Platform to be Featured in Multiple Oral Presentations at 42nd Annual Meeting of The Macula Society

  Clearside Biomedical, Inc. announced that multiple oral presentations will be given at the 42nd Annual Macula Society Meeting being held February 13-16, 2019 in Bonita Springs, Florida.

  February 14, 2019

   · 

  5 min read
• 

  Job Trends

  Axovant Launches Arvelle Therapeutics to Commercialize Epilepsy Drug

  Axovant Sciences, one of Vivek Ramaswamy’s biotech companies under the Roivant Sciences’ umbrella, is forming a company called Arvelle Therapeutics. Arvelle is a strategic transition of Axovant’s legacy small molecule team.Biopharmaceuticals

  February 14, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Job Trends

  BioSpace Movers and Shakers: Feb. 15

  Pharma and biotech companies strengthen their leadership teams with new hires and appointments at Cadent, bluebird, Abeona, Sanofi, and more.

  February 14, 2019

   · 

  5 min read

   · 

  Alex Keown
• Blindfolded training could help doctors save young lives

  Doctors’ leadership in pediatric resuscitation improved most when they wore a blindfold during simulation training

  February 14, 2019

   · 

  3 min read
• Recipharm announces all its facilities are ready for EU serialisation

  Recipharm announced that all fifteen of its facilities outlined in its investment plan are now fully prepared for drug serialisation and have delivered serialised batches within Europe ahead of the February 9th deadline.

  February 14, 2019

   · 

  2 min read
• BIO-Europe Spring® comes to Vienna for Europe’s most important springtime life science partnering event

  The thirteenth annual BIO-Europe Spring®international partnering conference meets in Vienna, Austria, March 25–27, 2019, at the Messe Wien Exhibition and Congress Center.

  February 14, 2019

   · 

  3 min read
• Business

  GeoVax Issues Open Letter to HHS Secretary Alex Azar

  GeoVax Labs, Inc., a biotechnology company developing human vaccines, today published an open letter to U.S. Department of Health and Human Services Secretary Alex Azar in response to the HHS initiative “Ending the HIV Epidemic: A Plan for America.”

  February 14, 2019

   · 

  4 min read